BPG is committed to discovery and dissemination of knowledge
Articles in Press
1/29/2026 3:48:21 AM | Browse: 2 | Download: 0
Publication Name World Journal of Cardiology
Manuscript ID 116780
Country Italy
Category Medicine, Research & Experimental
Manuscript Type Review
Article Title Gut microbiota-derived metabolite trimethylamine N-oxide in major adverse cardiovascular events: Mechanisms, risk assessment, and therapeutic strategies
Manuscript Source Invited Manuscript
All Author List Samuel Jaimez Alvarado, María Fernanda Flores Enciso, Amedeo Amedei and María Magdalena Aguirre García
Funding Agency and Grant Number
Funding Agency Grant Number
Dirección General de Asuntos del Personal Académico-Programa de Apoyo a Proyectos de Investigación e Innovación Tecnológica IN219025
Consejo Nacional de Humanidades, Ciencias y Tecnologías CBF2023-2024-734
Corresponding Author Amedeo Amedei, Full Professor, Department of Experimental and Clinical Medicine, University of Florence, Largo Brambilla, 3, Florence 50134, Tuscany, Italy. amedeo.amedei@unifi.it
Key Words Trimethylamine N-oxide; Major adverse cardiovascular event; Atherosclerosis; Prognosis biomarker; 3,3-dimethyl-1-butanol; Fluoromethylcholine
Core Tip Trimethylamine N-oxide (TMAO) is increasingly proposed as a prognostic biomarker and therapeutic target in cardiovascular disease, yet its clinical signal is strongly shaped by renal function and cardiometabolic comorbidity. We synthesize evidence linking TMAO to risk stratification, including incremental value beyond GRACE in acute coronary syndrome, highlight mechanistic advances from microbiota-targeted trimethylamine-lyase inhibitors, 3,3-dimethyl-1-butanol/fluoromethylcholine, that improve vascular and cardiac phenotypes in preclinical models, and outline a precision-nutrition framework that tailors TMAO-lowering strategies to individual producer metabotypes.
Citation Jaimez Alvarado S, Flores Enciso MF, Amedei A, Aguirre García MM. Gut microbiota-derived metabolite trimethylamine N-oxide in major adverse cardiovascular events: Mechanisms, risk assessment, and therapeutic strategies. World J Cardiol 2026; In press
Received
2025-11-20 05:40
Peer-Review Started
2025-11-20 06:25
First Decision by Editorial Office Director
2025-12-09 08:40
Return for Revision
2025-12-09 08:40
Revised
2025-12-22 20:28
Publication Fee Transferred
Second Decision by Editor
2026-01-29 02:33
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-01-29 03:48
Articles in Press
2026-01-29 03:48
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1949-8462 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com